Species of Scedosporium and Lomentospora are considered as emerging opportunists, affecting immunosuppressed and otherwise debilitated patients, although classically they are known from causing trauma-associated infections in healthy individuals. Clinical manifestations range from local infection to pulmonary colonization and severe invasive disease, in which mortality rates may be over 80%. These unacceptably high rates are due to the clinical status of patients, diagnostic difficulties, and to intrinsic antifungal resistance of these fungi. In consequence, several consortia have been founded to increase research efforts on these orphan fungi. The current review presents recent findings and summarizes the most relevant points, including the Scedosporium/Lomentospora taxonomy, environmental distribution, epidemiology, pathology, virulence factors, immunology, diagnostic methods, and therapeutic strategies.
Introduction
Nearly all pathogenic fungi are present in the environment adapted to very different habitats where they play varying roles in recycling of organic matter. With some of their causative agents being either opportunistic or primary pathogens, fungal infections show an increasing incidence worldwide, affecting millions of individuals, with mortality rates that may be higher than 50% in susceptible patient populations. 1 Among pathogenic fungi, Scedosporium species, including Lomentospora prolificans (formerly Scedosporium prolificans), 2 can cause infections in both immunocompetent and immunocompromised hosts, where they can act as primary or opportunistic pathogens. 3, 4 These species cause a broad range of clinical manifestations, from colonization of the respiratory tract, superficial infections and allergic reactions, to severe invasive localized or disseminated mycoses. Patients at risk are particularly those immunocompromised and with hematological malignancies. 3, 5 Individuals suffering from near-drowning events in water polluted with fungal propagules are also at risk of infections with central nervous system (CNS) involvement. 5 Moreover, Scedosporium/Lomentospora are among the most commonly recovered fungi from respiratory secretions of patients suffering from chronic pulmonary conditions such as cystic fibrosis (CF). 6 Although they are mostly asymptomatic colonizers, 7, 8 this may be the first step toward pathology. L. prolificans typically causes disseminated infections in immunocompromised patients, where it is associated with high mortality. 3, [8] [9] [10] [11] Scedosporium boydii and S. apiospermum are the most frequently isolated species, but in some regions S. aurantiacum is more common. The high degrees of intrinsic antifungal resistance make these infections difficult to manage. 12 The high mortality rates of deep and disseminated infections necessitate focusing resources and efforts to cope with the challenges posed by Scedosporium and Lomentospora species, such as improving diagnostic methods, or designing new effective therapies.
Therefore, the members of the Scedosporium working group of the International Society for Human and Animal Mycology (ISHAM), present at their 5 th Workshop in Bilbao in 2016, decided to prepare a detailed review describing the taxonomy, environmental distribution, epidemiology, pathology, virulence factors, immunology, diagnostic methods, and available therapeutic strategies.
Taxonomy, DNA barcoding, and new species
The nomenclature of the genus Scedosporium/Pseudallescheria has undergone numerous changes over the last decade following the introduction of molecular phylogenetics, which led to an increasing resolution at and below the species level. In addition, the fundamental change in fungal taxonomy allowing only a single name per fungal species, effectively abolishing the dual nomenclature based on the anamorph/teleomorph concept, 13 resulted in the adoption of the name Scedosporium at the expense of Pseudallescheria. 2 The first comprehensive revision of the genus conducted in 2005 by Gilgado et al.
14 using four genetic loci (β-tubulin (BT2 (= exon 2-4) and TUB (= exon 5-6)), calmodulin and the internal transcribed spacer regions (ITS1/2) of the rDNA gene cluster) recognized S. apiospermum (incl. P. boydii) as a species complex, in addition to S. aurantiacum and S. minutisporum. Within the S. apiospermum/P. boydii complex, three existing species were recognized: P. angusta, P. ellipsoidea, and P. fusoidea. 14 A second revision further recognised a new species S. dehoogii and maintained S. apiospermum and P. boydii as distinct species based on TUB sequences together with morphological and physiological criteria. 15 A significant genetic diversity within the S. apiospermum/P. boydii complex was noted in sequence analysis of the D1/D2 region of the LSU of rDNA, ITS1/2 and elongation factor 1-alpha; 16 ITS1/2 and BT2 17, 18 and the actin, BT2 and small ribosomal protein 60S L10 (RP60S) sequences in combination with AFLP analysis. 19 While the use of some loci, such as BT2, show better discriminatory resolution, barcoding of the ITS1/2 regions is sufficient for distinction of all relevant entities in clinical practice. 19 Rainer and Kaltseis (2010) described a new species S. deficiens, 20 closely related to S. dehoogii based on ITS1/2 and BT2 corresponding with growth differences on polyvinyl alcohol agar supplemented with diesel and rapeseed oil, and growth at 41
• C, but no reference sequences were submitted to any public database, and insufficient proof of novelty was provided. Recently another new species phylogenetically related to S. aurantiacum was described, based on ITS, BT2 and calmodulin, named S. cereisporum. 21 In summary, after the One Fungus = One Name movement 22 and sequencing studies, the genus Scedosporium now contains the following 10 species: S. aurantiacum, S. minutisporum, S. desertorum, S. cereisporum, and S. dehoogii, in addition to the S. apiospermum complex that comprises S. angustum, S. apiospermum, S. boydii, S. ellipsoideum, and S. fusarium ( Fig. 1) . A phylogenetic analysis of 104 TUB sequences ( Fig. 1 ), representative of all subgroups found among 407 analyzed TUB sequences, as well as an analysis of the intra-species variation of all 10 currently accepted Scedosporium species revealed high genetic variation within S. dehoogii, S. boydii, and S. apiospermum (Fig. 2 ), indicating that those should be treated as species complexes, and the identified subclades may indicate cryptic species. This was also confirmed by DNA barcoding gap analysis carried out on 538 ITS (Fig. 3A) and 407 TUB sequences (Fig. 3B) , showing that there is no barcoding gap within the genus Scedosporium if all current ten species are included. The loss of the barcoding gap is due to the high genetic variation found within S. dehoogii, S. boydii, and S. apiospermum. However, the description of those subclades as separate species needs further study, including molecular data in association with morphological, physiological, and clinical relevant data. There are clear barcoding gaps between S. minutisporum, S. desertorum, S. aurantiacum, and S. cereisporum (Fig. 3C ) indicating that they are well-defined species. The separation of S. angustum and S. fusoideum needs to be further investigated, taking into account the low genetic diversity within and between those two species, when compared to the genetic variation found in S. dehoogii, S. boydii, and S. apiospermum ( Fig. 1 and 2) . Finally, L. prolificans was shown to be unrelated to Scedosporium and therefore was Nucleotide diversity (π) in % and number of polymorphic sites (S) in the ITS1/2 regions (dark blue bar and light blue line, respectively) and β-tubulin gene (TUB, exon 5 and 6) (red bar and green line, respectively) of the nine of the ten currently accepted Scedosporium species for which sequences from more than one strain were available.
reclassified as Lomentospora prolificans, 23 and the genus Lomentospora was reinstated for this species. 
Environmental distribution and epidemiology
Knowledge of the ecological niches of Scedosporium/ Lomentospora species is essential for a better understanding of the dispersal of these fungi and for the potential identification of a source of an infection.
Ecological aspects
Scedosporium and Lomentospora species have been isolated from a wide range of environments, including anthropogenic influenced habitats, 24, 25 oil-soaked soils, cattle dung, and sewage. 26 In addition, polluted waters have been described as reservoirs specific for these fungi, and these were identified as sources of infection after near-drowning events. 27 However, adjacent agricultural soils were found to be colonized in a greater magnitude than water or sediment, suggesting the former is a main habitat of these fungi. Subsequent investigations concerning the ecology of Scedosporium species confirmed the correlation between their abundance and human impact on environments. 25, [28] [29] [30] [31] Agricultural areas 30 as well as playgrounds and soils in urban surroundings 25, 32 were consistently found to be heavily colonized. Scedosporium spp. are described to degrade alkanes, 20, 26 and therefore it is not surprising that they are responsible for 10% of the fungi found in leachate from soil remediation. 31 The impact of alkanes and elevated temperature on the soil mycobiota was studied in laboratory models. It was shown that the abundance of Scedosporium spp. (mainly S. apiospermum and S. dehoogii) correlates with diesel fuel concentration and elevated temperatures (10% w/v and 25
• C were tested, respectively). The number of Aspergillus and Penicillium isolates decreased in the same system (Eggertsberger M, unpublished results). In this context it should be mentioned that the temperature in urban soils, that is, in traffic islands can reach more than 30
• C even in temperate climates. 33 The occurrence of Scedosporium spp. is also influenced by the pH of the substrate, with an optimum of 6-8. Only few colonies were recovered from acidic (like most of the forest soils) or basic (as French seashores) soils. Another slight but positive correlation was postulated by Kaltseis et al. 25 concerning fungal density and nitrate concentration in soil. In industrially fertilized crop-fields less Scedosporium colonies were isolated than in biologically managed fields without mineral fertilizing regimes (Mall B, unpublished results). Concerning nitrogen usage, it should be pointed out that Scedosporium spp. can use complement compounds of the innate immune system in liquor as nitrogen source. 34 As an additional ecophysiological feature that helps to survive in the human host, the siderophore production of Scedosporium spp. in slightly acidic substrates could be of interest. 35 Furthermore, S. apiospermum, S. aurantiacum, and L. prolificans were identified by molecular analyses in mesophilic bagasse composts in 3.8%, but it seems to be unclear whether the identification method excluded S. boydii.
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Distribution patterns of the Scedosporium species show regional differences. 25, 28, 30 In Australia, S. aurantiacum accounted for more than 50% of all environmental isolates studied, whereas S. apiospermum and S. dehoogii are predominant in Austria and France, respectively. Ecological preferences were observed, for example, in the abundance of S. dehoogii in the presence of high levels of human activity. 25, 30 For its part, S. aurantiacum is characteristic of agricultural areas in the west of France. 30 
Clinical epidemiology
Species-specific patterns, host risk groups, organ-specific predilection, and in vitro antifungal susceptibilities, 8, 10, 18, [37] [38] [39] underline that understanding of the epidemiology is essential to clinical management. Scedosporium apiospermum and S. boydii have a worldwide distribution; by contrast, L. prolificans is rarely encountered in environmental samples and appears more commonly in the arid climates of Australia and Spain. 8, 9, 39, 40 More recently, L. prolificans has been recognized in other European countries, the USA and Korea. 11, 38, [41] [42] [43] Many S. aurantiacum infections have been reported from Australia, 8, 39 the Netherlands, 44 and Japan. 45 The epidemiological features between the three main groups of pathogens within Scedosporium and Lomentospora are summarized in Table 1 .
Immunocompromised hosts
Solid organ transplant (SOT) and hematopoietic stem cell transplant (HSCT) patients account for a large proportion of patients at high risk for invasive Scedosporium/ Lomentospora infections. However, individuals with cancer and other immunodeficiencies are also at risk for these mycoses. For SOT and HSCT patients, the risk of dissemination varies with the type of transplant and immunosuppressive regimen, degree and duration of neutropenia, environmental exposure, and type of antifungal prophylaxis. 8, 38, 42, 46, 47 Comparison of infection incidence in these patients across studies is difficult due to the use of different denominators. In a population-based survey, Heath et al. 8 reported an incidence of 1/100 000 population, of which two-thirds of cases occurred in SOT patients. Regarding two studies in the USA series, Scedosporium/Lomentospora infections accounted for 25% of all non-Aspergillus mould infections in transplant recipients (SOT, 29%; HSCT 71%), 38 while in another study of a HSCT cohort a frequency of 1.11 cases/100 000 patientinpatient days was reported. 48 In the first report, Husain et al. 38 found that disseminated disease occurred more often in HSCT (69%) than in SOT recipients (53%), particularly by L. prolificans (39% vs. 17%; P = .05), with infections in HSCT recipients having an earlier median onset (1.3 months vs. 4 months, P = .007), being more fungaemic (33% vs. 11%, P = .04), and strongly related to neutropenia (67% vs. 9%, P < .001). Additionally, HSCT recipients were more likely to have received prior antifungal prophylaxis (64% vs. 17%), and those that received antifungal prophylaxis tended to have later onset of Scedosporium/Lomentospora infections compared to those who did not (median time to onset, 4 vs. 2.3 months). 38 The earlier occurrence of disease after HSCT, generally during the pre-engraftment period has been noted. 3, 49 According to this, predictors of invasive disease have included HSCT and leukemia, with acute leukemia and L. prolificans infection predicting death. 8 Doligalski et al. 50 describe Scedosporium infections in 3.5% of the patients after lung transplantation, and the 3-month all-cause mortality was 21.7%. In a single center, 16 out of 27 SOT patients were considered colonized with Scedosporium, colonization being relatively common in lung transplant recipients (73%). 42 Invasive disease occurred in 11 patients (41%) with L. prolificans and S. apiospermum species complex causing 41% and 55% of cases, respectively. The 6-month mortality was 55%, similar to other studies. 8, 38 Over two-thirds of patients who developed Scedosporium infections had received immunosuppression with alemtuzumab or anti-thymocyte globulin, which may account for the higher mortality given their profound immunosuppression. Regarding clinical manifestations of Scedosporium/Lomentospora infections in SOT and HSCT patients, they may range from sinopulmonary disease and brain abscess to disseminated infection and aneurysms, which are often fatal. [51] [52] [53] [54] Infections caused by Scedosporium/Lomentospora uncommonly occur in patients with hematological malignancy, 43, 55, 56 advanced human immunodeficiency virus (HIV) infection, 57 and primary immunodeficiency disorders. 58, 59 These mycoses have attributable mortality of up to 77% in patients with acute leukemia. 55 As with HSCT recipients, patients with hematological malignancy are more likely to be neutropenic at the time of diagnosis of Scedosporium/Lomentospora infections and to have disseminated disease. 8, 49, 56 On the other hand, Tammer et al. 57 reviewed
22 HIV-infected patients with detection of Scedosporium species in clinical specimens; invasive scedosporiosis was proven in 54.5% of patients, among them dissemination occurred in 66.7% with a mortality rate of 75%. Patients with invasive scedosporiosis were more likely to have CD4 cell counts <100/μl. Cases of Scedosporium/Lomentospora infections in patients with chronic granulomatous disease (CGD) have been described. [58] [59] [60] Most of these infections involved the lung or soft tissue although disseminated infection has been reported, with S. apiospermum accounting for most of them. Moreover, breakthrough infections have been described in patients who were on long-term antifungal treatment or prophylaxis.
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Non-immunosuppressed hosts Scedosporium species are classically known from traumatic infections, leading to arthritis of eumycetoma, and from pulmonary colonization, often in preformed cavities, eventually leading to allergic bronchopulmonary mycosis. Colonization of lungs of patients with CF by Scedosporium/Lomentospora species is well established and the rate ranges between 0 and 21%, [61] [62] [63] [64] being the second most frequent species after A. fumigatus. 7 Species prevalence in these patients varies within the region studied: S. boydii was the most frequent species (62%) in a French cohort, followed by S. apiospermum (24%), S. aurantiacum (10%), and S. minutisporum (4%). 65 In a study performed in German CF patients, S. apiospermum was the most frequent species (49%) followed by S. boydii (29%), L. prolificans (12%), S. aurantiacum (5%), and S. minutisporum (5%). 66 In contrast, L. prolificans was the most frequent species isolated in patients with CF in Northern Spain. 67 In Australia, the most frequent species seems to be S. aurantiacum followed by L. prolificans and S. apiospermum. 68 Scedosporium dehoogii has rarely been isolated in human infections and to our knowledge never causing colonization in the airways of CF patients. Numerous cases of S. apiospermum eumycetoma have been described in the literature, mostly affecting the lower limbs. These infections are found worldwide including temperate regions. Case reports on eumycetoma from Europe, United States, and Brazil were ascribed to S. apiospermum/ S. boydii [69] [70] [71] [72] but mostly identified with classical methods so that it cannot be ascertained whether S. aurantiacum or S. dehoogii were involved in any of these cases. A special category is formed by cerebral infection after near-drowning. The etiologic agents are reportedly members of the S. apiospermum complex, but most data were published prior to molecular species distinction. Tintelnot et al. 73 re-identified 11 isolates and showed that most of the isolates belong to S. apiospermum sensu stricto, although S. boydii and S. aurantiacum were also identified. 73, 74 Furthermore, S. aurantiacum has been reported from a survivor of a tsunami in Japan. 45 To date, L. prolificans has not been reported in this clinical context.
Human pathology
The patients' immune status and fungal portal of entry seem to play an important role in the clinical course of Scedosporium / Lomentospora infections. Patients with fully competent immune systems may be asymptomatically colonized or locally infected. On the other hand, in patients with trauma involving major vessels, with severe injuries in the vicinity of the CNS, or with immune dysfunction, invasive infections are frequently found.
Colonization
Scedosporium colonization of the airways in patients with CF usually starts during adolescence, becoming chronic in up to 54% of patients having Scedosporium positive cultures (unpublished data), with one predominant strain that can be identified over several years. 67, 75, 76 Bronchial colonization may lead to chronic inflammation or even to life-threatening invasive disease in cases of severe immunosuppression, such as lung transplant or hematological malignancies. 3, 5, 77, 78 Of interest, Scedosporium conidia are rarely found in the air 79 so that the exact mechanism leading to airway colonization remains to be ascertained. Moreover, the presence of Scedosporium/Lomentospora in respiratory secretions of patients suffering from non-CF bronchiectasis is scant and tends to be associated with preexisting cavities, leading to eumycetomas and pulmonary fungus balls. 78 ABPA and mucoid Pseudomonas aeruginosa colonization are positively correlated with Scedosporium/Lomentospora colonization. 80 In this sense, it is worth highlighting that a recent study has shown that P. aeruginosa is able to inhibit S. aurantiacum and L. prolificans growth, with this inhibition being associated but not limited to the non-mucoid phenotype of the bacterium. 81 Revealing the epidemiology of human colonization by Scedosporium/Lomentospora is further hampered by the fact that they are slow growing moulds. Molecular strategies of detection have been proposed, 82, 83 revealing rates of colonization higher than those assessed by culture. Unfortunately, there are no molecular techniques commercially available for this purpose, making the general implementation of this approach into the clinical laboratories difficult.
Allergic bronchopulmonary mycoses
Scedosporium, but not Lomentospora, has been linked to clinical cases of allergic bronchopulmonary mycoses (ABPM), 7 with 3% of the ABPM cases reported in the literature being related to Scedosporium species. While it is not clear to what extent colonization drives long-term decline of pulmonary function, cases of Scedosporium-related ABPM have been linked to a clear respiratory deterioration of patients. 84 The clinical picture of ABPM caused by non-Aspergillus species tends to differ from classical allergic bronchopulmonary aspergillosis (ABPA), with asthma being less frequent and with higher immunoglobulin E (IgE) levels. Promising serological methods aimed at the specific detection of antibodies against Scedosporium are under development 85 but still not available.
Localized infections
Localized infections by Scedosporium/Lomentospora species include different organs and clinical manifestations:
(1) cutaneous infections; (2) eumycetoma; (3) muscle, joint and bone infections; and (4) ocular infections.
Cutaneous infections
Skin manifestations may be the initial presentation of a subcutaneous scedosporiosis after traumatic inoculation, or a sign of hematogenous dissemination (Fig. 4A) contiguous spread from an adjacent site. However, in immunocompromised patients, endophthalmitis is usually part of disease dissemination, secondary to parenteral nutrition or chemotherapy. Endophthalmitis curses with ocular pain, photophobia, and blurred vision, these symptoms not being specific for scedosporiosis. Fundoscopic examination shows creamy-white, well-circumscribed lesions of the choroids and retina, vitreous infiltrates and hypopyon.
3,91,92
Disseminated Infections
Scedosporium/Lomentospora disseminated infection (SDI) usually takes place in severely immunocompromised hosts, such as patients with cancer and hematological malignancies, hematopoietic stem cells or solid organ transplant recipients, patients with immunodeficiency, and those receiving immunosuppressive therapy. 3, 5, 50, [93] [94] [95] It happens following hematogenous spread from lungs, skin, or any source of localized infection. Recently, a disseminated infection in three patients after transplantation of a nearlydrowned donor has been reported. 96 As well as in other invasive fungal infections, SDI may result in a wide spectrum of syndromes, depending on the primary focus, patient´s immune status, and time of evolution of the disease.
Central nervous system (CNS) infections
This is a severe manifestation of disseminated infection (Fig. 4B) 
103,104
Systemic infection This is the most catastrophic expression of disseminated infection (Fig. 4C) 
Host-pathogen interactions: immune response and fungal virulence factors
The host immune response is a complex network of cellular and molecular mechanisms that can determine patient survival but, on the other hand, fungal cells have also developed strategies to evade immune responses and to overcome stressful conditions encountered inside the host 110 (see Fig. 5 ).
Host immune response
As the infectious propagules of Scedosporium/Lomentospora species are able to invade the host through a range of different sites (including: airways, puncture wounds, etc.), the immune responses also vary, with different immune cells and pathways being challenged to clear them. 3 Thus, general barriers as epithelia with the mucociliary system, tissue-resident immune cells, and the secretion of defense molecules play essential roles in the immune response to these infections. 111, 112 In these first stages of fungal invasion, recognition of fungal cells is mediated by pattern recognition receptors (PRRs), 113, 114 but only dectin-1 and
TLRs have been studied and proved to be determinant in the recognition of Scedosporium cells. [115] [116] [117] Although there are structural and compositional differences among species of the S. apiospermum complex, peptidorhamnomannans, rhamnomannans, and α-glucans from the fungal cell wall seem to be relevant pathogen associated molecular patterns.
116,118-120
After recognition by PRRs, phagocytes, including macrophages, neutrophils, and dendritic cells (DC), 121 and other cells with phagocytic capacity promote fungal death, growth delay or inhibition and recruit polymorphonuclear leukocytes (PMNs) by synthesis of pro-inflammatory cytokines. 122, 123 Conidia of L. prolificans seem to be phagocytized in a manner comparable to Aspergillus, at least by monocyte-derived macrophages, 124 despite the larger size of its conidia. 105 In contrast, germination of L. prolificans conidia is inhibited less efficiently than that of A. fumigatus conidia. 124 Although the cytokines locally expressed during Scedosporium infection have been poorly studied, interferon γ (IFN-γ ) and GM-CSF have been described to enhance the activity of phagocytes against Scedosporium species. [125] [126] [127] It is also known that interleukin (IL) 15 increases IL-8 release from PMNs and enhances PMN-induced hyphal damage and oxidative burst against L. prolificans. 128 Additionally, compared to Aspergillus species, L. prolificans has been shown in vitro to induce higher synthesis of tumor necrosis factor α (TNF-α) and IL-6 by human monocytes, 129 in relation with differences in the cell wall composition. In general, these cytokines are important to resist invasive infections by promoting respiratory burst and monocyte and neutrophil migration. species. This, together with susceptibility of Scedosporium/ Lomentospora species to phagocytosis, 124,132,133 may explain their low incidence in the immunocompetent population. In case ingested Scedosporium/Lomentospora conidia achieve germination and growth out of the alveolar macrophages, neutrophils and circulating monocytes attracted to the infection site become essential. 124 Although primary macrophages are able to damage hyphae, the major part of this role falls upon neutrophils via degranulation, release of large amounts of reactive oxygen species (ROS), and formation of neutrophil extracellular traps (NET), which trap fungal cells in a matrix mainly composed by DNA and proteins with antimicrobial activity. 121, 124, 132, 133 Antigen-presenting cells, mainly DCs, internalize and present potential antigens to T cells, which differentiate into T helper (T H ), T cytotoxic (T c ), or regulatory T cells (T reg ), depending on the stimulus and PRR involved. 114 In this way, "innate" is connected with "adaptive" or long-term immunity in which mainly T H 1, T H 2, and T H 17 cells 114, 134, 135 conform the best known antifungal response, but little is known about their specific role against Scedosporium/Lomentospora species. On the other hand, B cells are usually activated through T H cells to produce antibodies whose role in immunity has long time remained unclear. 136 Many antigenic proteins have been recently identified in S. boydii 85, 137 and L. prolificans, [138] [139] [140] and some of the antibodies recognizing them might be protective. 141 Interestingly, L. prolificans conidia are more strongly recognized by salivary immunoglobulin A (IgA) than hyphae, while sera recognize both forms similarly. This observation is consistent with a fungal airway invasion in which conidia rather than hyphae are inhaled by the host.
Virulence factors
The ability of Scedosporium/Lomentospora species to germinate is remarkable, which in the case of S. boydii has been described to be enhanced by contact with human cells.
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L. prolificans is capable of conidiation in host tissue, which promotes dissemination and explains the rapid progression of the disease. 143 Among the specific molecules, some peptidopolysaccharides are immunologically active, able to regulate pathogenesis and host immune response. 144 Of these, peptidorhamnomannan (PRM), which is expressed on both conidia and hyphal cell walls and has been related to fungal adhesion and endocytosis by epithelial cells and macrophages, deserves special attention. 142,145-147 PRM may facilitate colonization, virulence, and dissemination by the fungus as consequence of an exacerbation of the infection process that reduces the inflammatory response. 148 Moreover, PRM is recognized by antibodies, which is useful for development of diagnostics. 149 S. boydii-derived rhamnomannans require TLR-4 signaling for cytokine release by macrophages, as well as MAPKs phosphorylation and IκBα degradation. 120 Glucans have widely been reported as ligands for TLRs and activators of the immune response. S. boydii surface α-glucan, a glycogen-like polysaccharide consisting of linear 4-linked α-D-Glcp residues substituted at position 6 with α-D-Glcp branches, is essential to phagocytosis of conidia and induces cytokine secretion by cells of the innate immune system involving TLR2, CD14, and MyD88. 116 β-glucans are used as a diagnostic strategy for several fungal infections, but Scedosporium species release low levels of this polysaccharide.
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Glucosylceramides (GlcCer) or CMHs are the main neutral glycosphingolipids expressed by almost all fungal species studied so far, including species of the S. apiospermum species complex. 151, 152 These molecules are associated with fungal growth and differentiation and consequently play a role in the infectivity of fungal cells. [153] [154] [155] Structural differences between fungal and mammalian (or plant) CMHs make these molecules potential targets for the development of new antifungal drugs, to be used alone or in conjunction with conventional antifungals.
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Host invasion-related enzymes are further virulence factors of strategic relevance for Scedosporium species. 144 Among these are proteolytic enzymes, which are key components to invade tissues, eliminate defense mechanisms and assist in nutrient acquisition. A serine protease able to degrade fibrinogen was described in S. apiospermum, which might act as mediator of severe chronic inflammation in patients suffering from cystic fibrosis. 157 Moreover, some metalloproteases with ability to hydrolyze different substrates as IgG, laminin, fibronectin, or mucin have been described in S. boydii and S. apiospermum. [158] [159] [160] Scedosporium species are also able to degrade complement system compounds of the innate immune system. 34 Acid and alkaline ecto-phosphatase activities were also in mycelia of S. boydii. 161 In Candida spp. these have been related to adhesion and endocytosis, 162, 163 but limited information is available on their relevance to pathogenesis in Scedosporium. Enzymes such as Cu/Zn cytosolic superoxide dismutase 164 and a monofunctional catalase 165 from S.
boydii have been described to be important for evasion of the fungus to the host immune response, the latter being also useful for diagnostic purposes. 85 Two siderophores, dimerumic acid and N(α)-methyl coprogen B, were identified in S. boydii and the latter was used as a marker of the airway colonization by this species. 35, 166 The pigment melanin might contribute to virulence since it is a general protective component UV radiation and other kind of environmental stress. Lomentospora prolificans and S. boydii produce melanin through the dihydroxynaphthalene (DHN) biosynthetic pathway. 167, 168 While melanin plays a protective role in the survival of the opportunist to oxidative killing, it does not contribute to resistance to amphotericin B.
169

Diagnostics
Timely recognition of Scedosporium/Lomentospora infections remains challenging, particularly in patients with CF where airway infections still are a major cause of mortality. [170] [171] [172] Distinction of colonization from infection can be crucial for adequate patient management. The definition of pulmonary infection in CF includes the following criteria:
(1) increased sputum production, (2) repeated isolation of the same species from sputum or BAL (≥2x in 6 months), (3) pulmonary infiltrate(s) on chest CT-scan or X-ray, (4) treatment failure with antibiotic therapy, (5) unclear lung function decline, (6) exclusion of new/other bacteria (e.g., nontuberculous mycobacteria), and (7) exclusion of ABPA. Diagnosis classically relies on the detection of fungi from clinical samples by direct microscopic examination of the clinical specimen, or histological analysis, and culture on appropriate culture media (Fig. 4B-D) . Histopathological examination of biopsies can be performed to diagnose these mycoses, for example, using KOH treatment. Unfortunately, it is difficult to distinguish Scedosporium/ Lomentospora-infected tissues from those infected by Aspergillus or Fusarium, as all of them present hyaline hyphae (excluding L. prolificans that may exhibit highly melanised hyphae), regular hyphal septation, and dichotomous branching. However, several unique features may help pathologists to diagnose Scedosporium/Lomentospora mycoses, such as irregular branching patterns or intravascular and intratissue conidiation 3, 173 For isolation, semi-selective culture media are useful for the detection of Scedosporium and Lomentospora amidst competing and more rapidly growing microbes, particularly A. fumigatus. Sce-Sel+ media, containing dichloran and benomyl, 174 greatly facilitate recovery of Scedosporium species (N.B. benomyl inhibits growth of L. prolificans) from polymicrobial clinical samples. 68, 175, 176 Direct detection and identification from clinical samples by molecularbased techniques may also constitute a valuable alternative.
In this way, a species-specific multiplex PCR assay has been developed to detect the clinically most important Scedosporium/Lomentospora species from respiratory secretions.
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Morphologically and physiologically L. prolificans is easily differentiated from Scedosporium species based on its susceptibility to cycloheximide, the black color of its colonies, and its characteristic flask-shaped and annellated conidiogenous cells. However, species distinction within the S. apiospermum species complex is often impossible. Growth characteristics and utilization of carbohydrates or enzymatic activities, assist in main species differentiation but are inadequate for separation of lineages within the S. apiospermum complex, as demonstrated using the Taxa Profile Micronaut TM (Merlin Diagnostika GmbH, Germany) system, which analyzes 570 physiological reactions. 178 In S. aurantiacum, Biolog Phenotype analysis using GEN III MicroPlate TM (Biolog Inc., Hayward, CA, USA) containing 94 assorted substrates, reveals metabolic differences between high and low virulence strains, suggesting a link between virulence and ability to utilize D-turanose. 179 Nucleotide sequence-based analysis is the current gold standard for fungal identification. 17 rDNA ITS sequencing appropriately identifies the main species in Scedosporium/Lomentospora, 180 but the partial β-tubulin gene (BT2) is needed to differentiate closely related species. Of note, the status of some species like S. ellipsoidea, which is very close to S. boydii is still debated (see above). 2 Likewise, reversed line blot hybridization has been successfully applied in sputum samples from patients with CF. 82 Multilocus sequence typing (MLST) was used to analyze isolates from patients with CF, with three MLST schemes for S. apiospermum, S. boydii, and S. aurantiacum are now online at http://mlst.mycologylab.org. 76 Recently the analysis of some repetitive DNA sequences using the semi-automated Diversilab TM system from bioMérieux allowed the identification and genotyping within pathogenic Scedosporium species. 181 Matrix-laser desorption/ionization mass spectrometry (MALDI-TOF/MS) has become available for the first-line identification. It is more economical and its identification accuracy is comparable to that of DNA sequencing. [182] [183] [184] [185] The quality of the reference spectra is decisive for reliable identification (Fig. 6A) . The current commercially available MALDI-TOF/MS identification solutions are inadequate for Scedosporium/Lomentospora and it would be necessary the development of an online reference MALDI-TOF mass spectra library database, specialized in fungal identification, and curated by expert mycologists.
Among the novel assays is PCR-ElectroSpray IonizationTime of Flight/Mass Spectrometry (ESI-TOF/MS), which involves 16 singleplex polymerase chain reaction (PCR) assays using broad-range primers targeting nuclear or mitochondrial genes, and T2 magnetic resonance (T2MR). PCR-ESI-TOF/MS allows rapid determination of molecular weight and base composition in the amplicons after electrospray ionization and chromatographic separation, and resulting profiles are compared with a database provided by the manufacturer. [186] [187] [188] This technique has been used to determine the distribution of fungal communities directly from bronchoalveolar lavage fluid specimens.
189
T2MR technology rapidly and accurately detects the presence of molecular targets within a sample without the need for purification or extraction, 190, 191 but designing primers is challenging. 192 Specific monoclonal antibodies (MAbs) have been developed allowing for species distinction. 167, 193 Two MAbs targeting respectively an immunodominant carbohydrate epitope on an extracellular 120-kDa antigen present in the spore and hyphal cell walls of S. apiospermum and S. boydii or the tetrahydroxynaphtalene reductase of the dihydroxynaphtalene-melanin pathway in L. prolificans, may be used in immunofluorescence assay to differentiate these fungi from other septate fungal pathogens on histological sections.
Recently some Scedosporium proteins, including a monofunctional cytosolic catalase, proved to be interesting markers of a Scedosporium infection, and works are currently being performed in order to develop standardized serological tests. 85 In addition to proteomic approaches with MALDI-TOF or LC-MS/MS identification of Scedosporium/Lomentospora ribosomal equipment, 139, 182 mass spectrometry can be used in metabolomics to gain access to specific lowmolecular weight biomarkers. Melanin and its degradation products represent the first target in L. prolificans. Diverse lipids were also detected on intact spores of L. prolificans and S. apiospermum. 194 The metabolite AS-183
was detected in fermentation broth of Scedosporium spp. SPC-15549. 195 Siderophores have gained attention as disease biomarkers as well as virulence factors. 196, 197 Two siderophore representatives have been rigorously described in Scedosporium genus, dimerumic acid and N(α)-methyl coprogen B, 35 the former possibly being a degradation product of the latter. Siderophores may occur in various ionic forms in mass spectra. Generally, they are observed as ferri-or desferriforms, but combinations with sodium or potassium ions are possible depending on the sample type. 197 198 It is based on an integrated library of hundreds of microbial siderophores and secondary metabolites including toxins and nonribosomal peptides. Dereplication (the process of classifying already known compounds) can be performed on conventional mass spectra generated by any ionization technique as well as on liquid chromatography/mass spectrometry or imaging mass spectrometry datasets. These data formats are batch-processed and incorporation of important biometals (including iron) can be supported in calculations and data presentations. An example of a siderophore annotated in a sample of S. boydii by matrix-assisted laser desorption/ionization with Fourier transform ion cyclotron resonance (MALDI-FTICR) mass spectrum is illustrated in Figure 6B . It is worth mentioning that Cyclobranch is a free tool (available at http://ms.biomed.cas.cz/cyclobranch/) dedicated to exact mass data. In addition to dereplication, the de novo sequencing of new microbial structures is also possible. The calculator works with approximately 520 nonisobaric building blocks arising from ribosomal, nonribosomal or polyketide syntheses making the characterization of new siderophores 198 or cyclic, branched, or branched cyclic peptides 199 feasible.
Therapeutic strategies
Treatment of deep-seated Scedosporium or Lomentospora infections still remains challenging because of the limited susceptibility of these fungi to all current antifungal drugs. Scedosporium species are resistant to 5-flucytosine and amphotericin B, as well as to the first generation triazole drugs, fluconazole and itraconazole. In addition, they have a reduced susceptibility to echinocandins, particularly caspofungin and anidulafungin, and exhibit resistance to the most recent triazole drug, isavuconazole, S. aurantiacum being the least susceptible to antifungal drugs. 12, 66, 200 Likewise, L. prolificans is a pan-antifungal resistant species. 3, 12, 201 In this connection, it is also relevant to highlight that the available antifungal spectrum is quite limited, and as such more efforts need to focus on the development of novel effective drugs. 202, 203 For treatment of Scedosporium/Lomentospora infections, the European guidelines recommend voriconazole as first-line treatment 200 together with surgical debridement when possible. Although favorable results have been observed following such recommendations, the outcome remains poor with mortality rates of >65% and nearly 100% when CNS affectation or dissemination occurs. 204, 205 A minimum inhibitory concentration (MIC) of less than 2 μg/ml could be predictive of a favorable outcome for Scedosporium species. 206 Despite the differences on in vitro susceptibility among genera, the outcome remains similar especially when dissemination occurs. For this reason, it is of crucial interest to find therapeutic alternatives for these challenging and difficult-to-treat infections. Antifungal combination therapy has emerged as a promising strategy since therapeutic effect can be achieved at lower concentrations and thus reducing toxic side effects, improving safety and tolerability, shortening the therapeutic effect and preventing treatment failure when antimicrobial resistance is suspected. Few studies have evaluated the in vitro activity of double combinations against Scedosporium spp. and L. prolificans. Among them, combined voriconazole and amphotericin B or echinocandins have shown synergistic effects against both S. apiospermum and L. prolificans, [207] [208] [209] as well as terbinafine plus itraconazole, miconazole or voriconazole against L. prolificans. 3, 210, 211 However, the combination of voriconazole plus terbinafine or liposomal amphotericin B has demonstrated variable outcome in the treatment of these infections. [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] Limited data are available on combinations of more than two antifungals. Two triple combinations (amphotericin B plus voriconazole plus anidulafungin or micafungin) have been tested against L. prolificans and showed synergy 222, 223 .
The in vitro activity of combinations of antifungals with miltefosine, antipsychotic drugs or cysteine derivatives is being investigated as a potential treatment alternative. [224] [225] [226] It is also highlighting the capacity of inhibitors of Heat shock proteins, calcineurin and deacetylases against fungal species. 
Prospects in susceptibility to antifungals and resistance mechanisms
Among the drugs that are currently in the pipelines, one might be promising for treatment of Scedosporium/ Lomentospora infections. The Japanese company Eisai Co. discovered E1210, a new first-in-class broad spectrum antifungal drug acting in vitro against clinically important yeasts and molds, 241 and in vivo in experimental models of candidiasis, aspergillosis, and fusariosis. 242 This drug targets the inositol acylation step in the biosynthesis pathway of the glycosyl phosphatidyl inositol (GPI) anchor. GPIanchored cell wall proteins play a key role in fungal biology and virulence, and blockage of this metabolic pathway results in defects in cell wall biosynthesis, hyphal elongation and adherence of fungal cells to biological substrates. In vitro susceptibility testing using a large set of S. apiospermum (n = 28), S. aurantiacum (n = 7) and L. prolificans (n = 28) isolates revealed that MICs using E1210 were at least 10 fold lower than found in currently used drugs, including voriconazole. 243 This compound, which is licensed since 2015 by Amplyx (San Diego, USA-APX001) was approved on June 2016 by the FDA for treatment of candidiasis, invasive aspergillosis and coccidioidomycosis. Mutations in the "hot spot" regions of the Fks1 gene, encoding the catalytic subunit of the β-1,3-glucan synthase (the target of echinocandins), have been described, which may explain the reduced susceptibility of Scedosporium species and L. prolificans to echinocandins. 244 The low in vitro susceptibility (or primary resistance) of Scedosporium/Lomentospora species to azole drugs may result from resistance mechanisms similar to those extensively studied for A. fumigatus [245] [246] [247] [248] [249] such as point mutations in the coding sequence of CYP51A orthologues leading to a reduced affinity of azole drugs for their target, or constitutive overexpression of some efflux pumps. Specifically L. prolificans showed alterations in of shorter and wider hyphae and structural and compositional changes in the CW, possibly mediating L. prolificans resistance to VRC. 250 
Future trends in antifungal drugs
There are nowadays some very promising novel antifungal compounds, such as F901318 (Chen S, unpublished results) and N-chlorotaurine (NCT). The F901318 compound represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase, a key enzyme in pyrimidine biosynthesis. 251 The compound has been recently investi- The N-chloro derivative of the amino acid taurine is a long-lived oxidant generated by activated granulocytes and monocytes during inflammation and oxidative burst in phagolysosomes. 253 Moreover, it is more stable and much less toxic in vivo than HOCl. 254 In the 90s, the chemical synthesis of NCT as a crystalline sodium salt (Cl-HN-CH 2 -CH 2 -SO 3 Na) could be established, demonstrating broad-spectrum killing activity against microbes. 255, 256 Due to its unspecific mechanism of action, development of resistance is extremely improbable. Three key features of NCT contribute to its successful clinical application: (1) transhalogenation: 257 which makes the net microbicidal activity of NCT markedly enhanced in vivo, above all against fungi; (2) chlorine cover: Clinical phase I and II studies demonstrated very good tolerability of topical 1% (55 mM) NCT in aqueous solution for skin ulcers, conjunctivitis, external otitis, and oral infections. 256 Recently, inhaled 1% NCT was well tolerated in pigs, mice, and humans (pilot tests and a phase I study), respectively. [259] [260] [261] At this concentration, NCT was able to kill all Scedosporium species tested, that is, both hyphae and conidia of S. apiospermum, S. boydii, and L. prolificans, within several hours at pH 7.1 and 37
• C. 262 As expected, addition of ammonium chloride (NH 4 Cl) reduced the killing times to approximately 5 min because of transhalogenation. Indeed, LIVE/DEAD staining of conidia disclosed increased permeability of the cell membrane and wall, which is decisive for killing. However, short, sublethal incubation times of 10-60 min in plain NCT significantly increased germination time and decreased germination rate of conidia. Moreover, such sublethally treated conidia lost their virulence in vivo after injection into larvae of G. mellonella, so that the larvae survived similar to mock-injected controls.
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A second study was done to investigate NCT on its microbicidal activity in vitro in artificial sputum medium (ASM) mimicking the composition of cystic fibrosis mucus at 37
• C and pH 6.9. 263 Under these conditions, 1%
NCT killed bacteria and spores already within 10 min and 15 min, respectively, to the detection limit of 10 2 CFU/ml (reduction by 5-6 log 10 ). A reduction by 2 log 10 was still achieved by 0.1% (bacteria) and 0.3% (fungi) NCT largely within 10-30 min. This markedly more rapid killing (particularly of fungi) in ASM compared to phosphate buffer can be explained by transhalogenation. In this review, the state-of-the-art of the emerging opportunistic fungal pathogens Scedosporium/Lomentospora is discussed, mainly focusing on the scientific knowledge acquired in the last decade. Summarizing, in taxonomy the genus Lomentospora is clearly independent from Scedosporium, which currently contains ten species. These fungi are found in environments of high human activity, polluted waters and soils/composts, while their prevalence varies with geography, environmental pH and chemical content, especially aliphatic hydrocarbons. They infect immunosuppressed and immunocompetent individuals where near-drowning events pose a special risk. Furthermore, colonization of the respiratory tract is common in patients with chronic lung diseases such as CF.
The main virulence factors described are PRM and other cell-wall peptidopolysaccharides, proteolytic enzymes, superoxide dismutase, catalase, siderophores, and melanin. The immune status of the patient seems vital to control infections, being TLRs and Dectin-1 crucial for fungal recognition and phagocytosis. Specific response, including humoral, might also be of importance. The difficulty to detect and identify these fungi from nonsterile samples results in the fact that the real epidemiology remains to be undetermined, warranting future efforts on the improvement of conventional methods, molecular tools, detection of serological markers and secondary metabolites. A rapid and specific detection of the etiologic agent remains to be very important for the initiation of appropriate treatment. Regarding therapy, although several new strategies are being tested with promising results, nowadays a combination of two or even three anti-fungal drugs is recommended. Among the future perspectives, in addition to immunotherapy, NCT deserves to be mentioned because its broad-spectrum microbicidal activity, tolerability, and anti-inflammatory properties.
In conclusion, although great advances in Scedosporium/ Lomentospora have been made, much remains to be ascertained, including (1) the identification of definitive markers for the definition of species in Scedosporium that allow a better knowledge of its distribution and impact in human pathology, (2) a deeper understanding of its survival strategies and interaction with hosts, (3) the development of faster, accurate and easy-to-implement clinical tools for diagnosis, and (4) the finding of in vivo active compounds to treat the wide range of infections, many of the life-threatening, caused by these fungi.
